Literature DB >> 27749761

Microrna Expression Profiling of Macrophage Line Raw264.7 Infected by Candida Albicans.

Chuan-Xin Wu1, Jing Cheng, Yun-Ying Wang, Jiao-Jiao Wang, Hui Guo, Hang Sun.   

Abstract

INTRODUCTION: The aim of this study was to clarify the microRNA (miRNA) expression profiles of RAW264.7 macrophages infected by Candida albicans to elucidate the roles of differentially expressed miRNAs and to further explore the mechanisms underlying the immune response to C. albicans infection.
METHODS: High-throughput miRNA microarray analysis was performed to detect differentially expressed miRNAs in control and C. albicans-infected RAW264.7 cells. Quantitative real-time PCR analysis was used to verify the microarray results. Target genes of differentially expressed miRNAs were predicted with bioinformatics software. The cell biological processes and signaling pathways of these miRNA-targeted genes involved in C. albicans infection were predicted by gene ontology (GO) enrichment and pathway analyses.
RESULTS: Significant upregulation of eight miRNAs (mmu-miR-140-5p, mmu-miR-96-5p, mmu-miR-8109, mmu-miR-466i-3p, mmu-miR-222-5p, mmu-miR-301b-3p, mmu-miR-466g, and mmu-miR-7235-5p) and downregulation of eight miRNAs (mmu-miR-3154, mmu-miR-223-3p, mmu-miR-494-3p, mmu-miR-6908-5p, mmu-miR-188-5p, mmu-miR-6769b-5p, mmu-miR-7002-5p, and mmu-miR-1224-5p) were observed, as compared with the control (fold change ≥2.0 and P < 0.05). GO analysis revealed that both mmu-miR-140-5p and mmu-miR-223-3p participated in immune responses, inflammatory reactions, and cell apoptosis in C. albicans infection. Also, the MAPK signaling pathway was found to play an important role in the immune response against C. albicans infection.
CONCLUSIONS: This study revealed comprehensive expression and functional profiles of differentially expressed miRNAs in macrophage RAW264.7 cells infected by C. albicans. These findings should help to further elucidate the mechanisms underlying the immune response to C. albicans infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27749761     DOI: 10.1097/SHK.0000000000000766

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  [Continuous expression and functional prediction of circular RNA in mouse lung development].

Authors:  Xue Fu; Yang Yang; Yan-Qing Shen; Xiao-Guang Zhou; Xiao-Yu Zhou
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-10

2.  In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases.

Authors:  Ranjit Chauhan; David Datzkiw; Shailly Varma Shrivastav; Anuraag Shrivastav
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

3.  Oral Candida albicans colonization in healthy individuals: prevalence, genotypic diversity, stability along time and transmissibility.

Authors:  Ângela Gerós-Mesquita; Joana Carvalho-Pereira; Ricardo Franco-Duarte; Armandino Alves; Hernâni Gerós; Célia Pais; Paula Sampaio
Journal:  J Oral Microbiol       Date:  2020-09-14       Impact factor: 5.474

4.  Comprehensive circRNA-microRNA-mRNA network analysis revealed the novel regulatory mechanism of Trichosporon asahii infection.

Authors:  Ming-Wang Zhang; Zhi-Hong Zhu; Zhi-Kuan Xia; Xin Yang; Wan-Ting Luo; Jun-Hong Ao; Rong-Ya Yang
Journal:  Mil Med Res       Date:  2021-03-09

5.  Circulating Exosomal miRNA Profile During Term and Preterm Birth Pregnancies: A Longitudinal Study.

Authors:  Ramkumar Menon; Chirantan Debnath; Andrew Lai; Dominic Guanzon; Shinjini Bhatnagar; Pallavi K Kshetrapal; Samantha Sheller-Miller; Carlos Salomon
Journal:  Endocrinology       Date:  2019-02-01       Impact factor: 4.736

6.  Free circulating mircoRNAs support the diagnosis of invasive aspergillosis in patients with hematologic malignancies and neutropenia.

Authors:  Emese Tolnai; Gábor Fidler; Róbert Szász; László Rejtő; Kingsley Okechukwu Nwozor; Sándor Biró; Melinda Paholcsek
Journal:  Sci Rep       Date:  2020-10-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.